Abstract:Objective To investigate the relationship between lipid metabolism and cognitive function in elderly patients with Parkinson′s disease (PD) and anxiety. Methods A total of 90 elderly PD patients with concomitant anxiety admitted in our hospital from January 2021 to January 2024 were recruited and served as anxiety group, and another 70 age-matched PD patients without anxiety were enrolled and assigned into control group. The lipid levels and detection rate of cognitive impairment (CI) were compared between two groups. For the patients of the anxiety group, the detection rate of PD-CI was analyzed among those with different subtypes of lipid metabolism disorder. Binary logistic regression model was used to analyze the related factors affecting the occurrence of CI in elderly PD patients with anxiety. SPSS statistics 26.0 was used for statistical analysis. Data comparison between two groups was performed using t test or Chi-square test depending on data type. Results The anxiety group exhibited significantly higher detection rate of PD-CI, and increased levels of serum TC and TG than the control group (all P<0.05). For the patients from the anxiety group, the detection rate of PD-CI was higher in the hypercholesterolemia patients and mixed dyslipidemia patients than those with normal lipid metabolism (P<0.05). With whether PD-CI was detected in the anxiety patients as dependent variable, binary logistic regression analysis suggested that age of PD onset (OR=1.943,95%CI 1.373-2.748), H-Y grade (OR=3.114,95%CI 1.487-6.520), low or vague voice (OR=3.931,95%CI 2.357-6.557), rapid eye movement sleep behavior disorder (OR=2.008,95%CI 1.581-2.550), depression (OR=1.984,95%CI 1.408-2.795) and hypercholesterolemia (OR=2.210,95%CI 1.461-3.342) were risk factors affecting PD-CI (P<0.05). Conclusion PD patients with anxiety demonstrate higher incidence of CI, and more serious dyslipidemia. Concomitant hypercholesterolemia is an independent risk factor for CI in elderly PD patients with anxiety. In clinical practice, attention should be paid to lipid metabolism in PD patients, and life intervention and medication should be used to control hypercholesterolemia in order to reduce the risk of CI in later stage.